Scott’s Emulsion

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Medications are known to interact with Scotts Emulsion (multivitamin)

• • anisindione
  • bortezomib
  • capecitabine
  • cholestyramine
  • colesevelam
  • colestipol
  • dicumarol
  • fluorouracil
  • orlistat
  • sevelamer
  • warfarin SCOTT’S EMULSION DOSAGE

Pharmacodynamics

Side Effects:

Precautions

Dosage

Food(before/after)

List of Contraindications

Pregabalin+Mecobalamin and Pregnancy

Pregabalin+Mecobalamin and Lactation

Lab interference

• Rich in Vitamin A & (DHA) helps to maintain a healthy immune system also beneficial for healthy skin and eyesight.
• Rich in vitamin D For strong and healthy bones.
• Rich in Omega 3 have anti- inflammatory properties.
• (EPA)for the cardiovascular system and helps reduce inflammation.
• Free from Sugar, gluten and yeast containing ingredients.
• Free from artificial additives, preservatives or colors

• For the treatment of folate-deficient megaloblastic anaemia due to malnutrition, malabsorption syndromes (such as coeliac disease or sprue) and increased utilisation as in pregnancy. It should not be used alone in undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aetiology, unless administered with adequate amounts of hydroxocobalamin.
• For the prophylaxis of drug induced folate deficiency e.g., caused by administration of phenytoin, phenobarbital and primidone. (See section 4.5).
• For the prophylaxis against folate deficiency in chronic haemolytic states or in renal dialysis.
• For the prevention of neural tube defects for woman planning a pregnancy and known to be at risk

• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Long-term folate therapy is contraindicated in any patient with untreated cobalamin deficiency. This can be untreated pernicious anaemia or other cause of cobalamin deficiency, including lifelong vegetarians. In elderly people, a cobalamin absorption test should be done before long-term folate therapy. Folate given to such patients for 3 months or longer has precipitated cobalamin neuropathy. No harm results from short courses of folate
• Folic acid should never be given alone in the treatment of Addisonian pernicious anaemia and other vitamin B₁₂deficiency states because it may precipitate the onset of subacute combined degeneration of the spinal cord
• Folic acid should not be used in malignant disease unless megaloblastic anaemia owing to folate deficiency is an important complication.

• Patients with vitamin B₁₂deficiency should not be treated with folic acid unless administered with adequate amounts of hydroxocobalamin, as it can mask the condition but the subacute irreversible damage to the nervous system will continue. The deficiency can be due to undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aethiology or other cause of cobalamin deficiency, including lifelong vegetarians.
• Caution should be exercised when administering folic acid to patients who may have folate dependent tumours.
• This product is not intended for healthy pregnant women where lower doses are recommended, but for pregnant women with folic acid deficiency or women at risk for the reoccurrence of neural tube defects.
• This product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not take this medicine